Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Non-dilutive
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Psychiatry
TARGET USER
Clinicians
REGULATORY STAGE
Investigational
Eysz uses eye-tracking as a digital biomarker for neurological conditions, particularly concussion. Its non-invasive, software-based approach enables scalable screening but faces competition from other digital assessment tools.
.svg)
